Cancer Biology
  • Print
   
   

Midlands research powerhouse will use powerful new imaging technology to develop the next generation of drugs

 

The next generation of drugs to tackle two of the planet’s  biggest killers are to be developed through a partnership bringing together powerful Nobel Prizewinning imaging technology and some of the brightest scientific minds from around the globe.

The Centre of Membrane Proteins and Receptors (COMPARE) is a collaboration between the universities of Nottingham and Birmingham that will cement the Midlands’ position as a research powerhouse for academic drug discovery.

The new centre will be launched with an initial investment of £10 million. It will unite a team of more than 20 leading researchers from both institutions in the quest for more effective drugs with fewer side effects to treat cardiovascular disease and cancer, while working with the pharmaceutical industry to take the treatments from bench to bedside.

It will deliver globally important scientific discovery and develop the next generation of researchers with the skills to exploit new imaging techniques and facilities as a result of experience they will gain working with world-leading experts.

Read more

Posted on Wednesday 1st June 2016

Cancer Biology Unit

School of Medicine
The University of Nottingham
D Floor, West Block, Queen's Medical Centre
Nottingham, NG7 2UH


telephone: +44 (0) 115 82 31135
email:cancer-biology@nottingham.ac.uk